These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 35722723)
21. The role of skin tests with polyethylene glycol and polysorbate 80 in the vaccination campaign for COVID-19: results from an Italian multicenter survey. Montera MC; Giordano A; Asperti C; Aruanno A; Barzaghi CE; Bignardi D; Borrelli P; Bommarito L; Busa M; Calafiore P; Carusi V; Cinquini M; Cortellini G; Cocchi R; D'Auria F; De Caro F; Demonte A; Di Leo E; Di Lizia M; Di Rienzo A; Fumagalli F; Kihlgren P; Lodi Rizzini F; Macchia D; Manzotti G; Marra AM; Mileto P; Mietta S; Montagni M; Nettis E; Nucera E; Peveri S; Pivetta D; Pirisi M; Ramirez GA; Rivolta F; Rizzi A; Savoia A; Pedicini A; Scarpa A; Zambito M; Zisa G; Yacoub MR Eur Ann Allergy Clin Immunol; 2024 Jan; 56(1):17-25. PubMed ID: 36927838 [No Abstract] [Full Text] [Related]
22. Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI). Tuyls S; Van Der Brempt X; Faber M; Gadisseur R; Dezfoulian B; Schrijvers R; Froidure A; Acta Clin Belg; 2022 Jun; 77(3):552-557. PubMed ID: 33792500 [TBL] [Abstract][Full Text] [Related]
23. Vaccine hesitancy in patients presenting to a specialized allergy center: clinical relevant sensitizations, impact on mental health and vaccination rates. Kogseder N; Puxkandl V; Hoetzenecker W; Altrichter S Front Immunol; 2024; 15():1324987. PubMed ID: 38827735 [TBL] [Abstract][Full Text] [Related]
25. The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital. Paoletti G; Pepys J; Bragato MC; Paoletti S; Piona A; Messina MR; Racca F; Ferri S; Nappi E; Costanzo G; Del Moro L; Puggioni F; Canonica GW; Azzolini E; Heffler E Vaccines (Basel); 2023 Apr; 11(5):. PubMed ID: 37243007 [TBL] [Abstract][Full Text] [Related]
26. Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of testing with PEG 1500 extract. Gaspar A; Moura AL; Cruz C; Borrego LM Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):261-270. PubMed ID: 36458507 [No Abstract] [Full Text] [Related]
27. [Reasons for allergology consultations prior to COVID-19 vaccination and their outcomes : Two-year experience of an allergy center in North Rhine-Westphalia]. Leonidou Floruß E; Demidova A; Hofmann SC; Balakirski G Dermatologie (Heidelb); 2023 Jul; 74(7):511-519. PubMed ID: 37140637 [TBL] [Abstract][Full Text] [Related]
28. Allergy Workup in the Diagnosis of COVID-19 Vaccines-Induced Hypersensitivity Reactions and Its Impact on Vaccination. Petrelli F; Giannini D; Pucci C; Del Corso I; Rocchi V; Dolcher MP; Pieve G; Pratesi F; Migliorini P; Puxeddu I Int Arch Allergy Immunol; 2023; 184(1):54-62. PubMed ID: 36265449 [TBL] [Abstract][Full Text] [Related]
29. Assessment of Immediate Allergic Reactions After Immunization With the Pfizer BNT162b2 Vaccine Using Intradermal Skin Testing With the COVID-19 Vaccines. Shavit R; Maoz-Segal R; Offengenden I; Yahia SH; Maayan DM; Lifshitz Y; Niznik S; Deutch M; Elbaz E; Genaim H; Iancovici-Kidon M; Agmon-Levin N J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2677-2684. PubMed ID: 35973526 [TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 and allergy - what have we learned after two and a half years? Brockow K; Wang R; Mathes S; Bent R; Faihs V; Eberlein B; Darsow U; Biedermann T Allergol Select; 2023; 7():101-112. PubMed ID: 37056446 [TBL] [Abstract][Full Text] [Related]
31. Polyethylene glycol hypersensitivity, patient outcomes in a 7-year retrospective study. Kayode OS; Nakonechna A; Siew LQC; Dziadzio M; Kennard L; Rutkowski K; Mirakian R; Wagner A Ann Allergy Asthma Immunol; 2024 Jul; 133(1):93-100.e4. PubMed ID: 38561050 [TBL] [Abstract][Full Text] [Related]
32. Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines. Mouri M; Imamura M; Suzuki S; Kawasaki T; Ishizaki Y; Sakurai K; Nagafuchi H; Matsumura N; Uchida M; Ando T; Yoshioka K; Ooka S; Sugihara T; Miyoshi H; Mori M; Okada T; Yamaguchi M; Kunishima H; Kato M; Kawahata K Allergol Int; 2022 Oct; 71(4):512-519. PubMed ID: 35718709 [TBL] [Abstract][Full Text] [Related]
33. A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network. Neuhann JM; Stemler J; Carcas A; Frías-Iniesta J; Bethe U; Heringer S; Tischmann L; Zarrouk M; Cüppers A; König F; Posch M; Cornely OA Trials; 2022 Oct; 23(1):865. PubMed ID: 36209129 [TBL] [Abstract][Full Text] [Related]
34. [Vaccination approach in patients with an allergic reaction to COVID-19 vaccines or at risk of developing allergic reactions]. Özden Ş; Tepetam FM; Atik Ö Tuberk Toraks; 2023 Jun; 71(2):166-175. PubMed ID: 37345399 [TBL] [Abstract][Full Text] [Related]
35. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial. Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177 [TBL] [Abstract][Full Text] [Related]